Modulation of disease severity in mice with targeted disruption of the acid α-glucosidase gene
Nina Raben(APT Therapeutics (United States)), Paul H. Plötz(National Institutes of Health), Kanneboyina Nagaraju(Children's National), Eunice Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases)
Cited by 69
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395